background image

Paid Clinical Trials Iowa City

Discover 504 paid clinical trials in Iowa City, Iowa. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Development of Charcot Marie Tooth Disease (CMT) Pediatric Scale for Children With CMT

Recruiting

Sponsor:

University of Iowa

Location:

Iowa City IA, Ann Arbor MI, Rochester NY, Philadelphia PAshow 3 more

Code:

NCT01203085

Conditions

Charcot Marie Tooth Disease

Eligibility Criteria

Sex: All

Age: 0 - 21

Healthy Volunteers: Not accepted

Diamyd

Recruiting
PHASE3

Sponsor:

Diamyd Medical AB

Location:

Iowa City IA, St Louis MO, Aurora CO, Amarillo TXshow 8 more

Code:

NCT05018585

Conditions

Type 1 Diabetes Mellitus

Eligibility Criteria

Sex: All

Age: 12 - 28

Healthy Volunteers: Not accepted

Interventions

Recombinant human glutamic acid decarboxylase (rhGAD65) formulated in Alhydrogel®

Colecalciferol 2000 IU

Placebo

BMS-986340, Nivolumab, Docetaxel

Recruiting
PHASE1
PHASE2

Sponsor:

Bristol-Myers Squibb

Location:

Iowa City IA, Nashville TN, Hamilton, Ottawashow 9 more

Code:

NCT04895709

Conditions

Cervical Cancer

Gastric/Gastroesophageal Junction Adenocarcinoma

Microsatellite Stable Colorectal Cancer

Non-Small-Cell Lung Cancer

Squamous Cell Carcinoma of Head and Neck

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

BMS-986340

BMS-936558-01

Docetaxel

Palbociclib & Pembrolizumab

Recruiting
PHASE1

Sponsor:

John Rieth

Location:

Iowa City IA

Code:

NCT06113809

Conditions

Sarcoma

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Interventions

Palbociclib

Pembrolizumab

Genetic Registry

Recruiting

Sponsor:

Parkinson's Foundation

Location:

Iowa City IA, Evanston IL, Chicago IL, Milwaukee WIshow 42 more

Code:

NCT04994015

Conditions

Parkinson's Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Lab Assay for seven genetic variants for Parkinson's Disease

Interested in new trials?

Get alerts for new trials in your area by subscribing now

By submitting, you consent to the use of your personal details, including contact information and location, to respond to your request for information related to clinical trials, as outlined in the Privacy Policy. If at any time you want to discontinue receiving alerts, please click the Unsubscribe link in the email received.

Thrombectomy Platform

Recruiting

Sponsor:

Medical University of South Carolina

Location:

Iowa City IA, Chicago IL, St Louis MO, Edina MNshow 31 more

Code:

NCT06289985

Conditions

Ischemic Stroke

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Endovascular thrombectomy with any FDA-approved category POL or NRY device

Medical Management

Observational Study

Recruiting
EARLY_PHASE1

Sponsor:

Anna Stanhewicz, PhD

Location:

Iowa City IA

Code:

NCT05946785

Conditions

Gestational Diabetes

Vascular Endothelial Function

Eligibility Criteria

Sex: Female

Age: 18 - 50

Healthy Volunteers: Accepted

Interventions

Acetylcholine

insulin aspart

IDE196 & Crizotinib

Recruiting
PHASE2
PHASE3

Sponsor:

IDEAYA Biosciences

Location:

Iowa City IA, Rochester MN, St Louis MO, Burnsville MNshow 26 more

Code:

NCT05987332

Conditions

Metastatic Uveal Melanoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

IDE196

Crizotinib

Pembrolizumab

Ipilimumab

Nivolumab

SpotLight-THC

Recruiting
PHASE1

Sponsor:

ISBRG Corp

Location:

Iowa City IA

Code:

NCT05276232

Conditions

Cannabis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Interventions

Cannabis(THC) inhaled

REACT

Recruiting
PHASE3

Sponsor:

Prokidney

Location:

Iowa City IA, Madison WI, Chicago IL, Dakota Dunes SDshow 37 more

Code:

NCT05099770

Conditions

Type 2 Diabetes Mellitus

Chronic Kidney Diseases

Eligibility Criteria

Sex: All

Age: 30 - 70+

Healthy Volunteers: Not accepted

Interventions

Renal Autologous Cell Therapy (REACT)

Sham Comparator